Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

SELL
$13.1 - $14.95 $8.64 Million - $9.86 Million
-659,300 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$13.69 - $20.06 $2.26 Million - $3.32 Million
165,400 Added 33.49%
659,300 $9.25 Million
Q4 2018

Feb 12, 2019

SELL
$13.96 - $18.26 $1.09 Million - $1.42 Million
-77,800 Reduced 13.61%
493,900 $8.62 Million
Q2 2018

Aug 08, 2018

BUY
$13.44 - $17.59 $1.33 Million - $1.74 Million
98,800 Added 20.89%
571,700 $7.89 Million
Q4 2017

Feb 12, 2018

SELL
$11.73 - $14.75 $790,602 - $994,150
-67,400 Reduced 12.47%
472,900 $6.71 Million
Q3 2017

Nov 13, 2017

BUY
$12.06 - $14.12 $6.52 Million - $7.63 Million
540,300
540,300 $7.63 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.